Evolution of integrase resistance during failure of integrase inhibitor-based antiretroviral therapy.
Hatano
Hiroyu
H
University of California, San Francisco, CA, USA. hhatano@php.ucsf.edu
Lampiris
Harry
H
Fransen
Signe
S
Gupta
Soumi
S
Huang
Wei
W
Hoh
Rebecca
R
Martin
Jeffrey N
JN
Lalezari
Jacob
J
Bangsberg
David
D
Petropoulos
Christos
C
Deeks
Steven G
SG
D044966:Anti-Retroviral Agents / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use*; D018791:CD4 Lymphocyte Count; D024882:Drug Resistance, Viral; D005260:Female; D006678:HIV / Q000187:drug effects / Q000235:genetics / Q000502:physiology; D019427:HIV Integrase / Q000187:drug effects*; D019428:HIV Integrase Inhibitors / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D012367:RNA, Viral / Q000097:blood; D013997:Time Factors; D017211:Treatment Failure; D014779:Virus Replication / Q000187:drug effects
D044966:Anti-Retroviral Agents; D000998:Antiviral Agents; D019428:HIV Integrase Inhibitors; D012367:RNA, Viral; D019427:HIV Integrase